Research Article
Clinical Epidemiology Characteristics and Antibiotic Resistance Associated with Urinary Tract Infections Caused by E. coli
Table 3
Antibiotic sensitivity test results of E. coli isolates (N = 128).
| | Antibiotics | 2011–2013 | 2018–2020 | | n | Sensitive | Intermediate | Resistance | n | Sensitive | Intermediate | Resistance | | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) |
| | Ampicillin | 34 | 4 (11.8) | 1 (2.9) | 29 (85.3) | 70 | 2 (2.9) | | 68 (97.1) | | Augmentin | 39 | 11 (28.2) | 15 (38.5) | 13 (33.3) | | | | | | Cefotaxime | 49 | 23 (46.9) | 7 (14.3) | 19 (38.8) | 66 | 21 (31.8) | 1 (1.5) | 44 (66.7) | | Ceftriaxone | 44 | 21 (47.7) | 5 (11.4) | 18 (40.9) | | | | | | Nalidixic acid | 48 | 22 (45.8) | 3 (6.3) | 23 (47.9) | | | | | | Ciprofloxacin | 45 | 29 (64.4) | 11 (24.4) | 5 (11.1) | 70 | 46 (65.7) | 3 (4.3) | 21 (30) | | Gentamicin | 49 | 29 (59.2) | | 20 (40.8) | 70 | 47 (67.1) | | 23 (32.9) | | Amikacin | 46 | 40 (87) | 2 (4.3) | 4 (8.7) | 67 | 64 (95.5) | | 3 (4.5) | | Cotrimoxazole | 44 | 12 (27.3) | 1 (2.3) | 31 (70.5) | 70 | 13 (18.6) | | 57 (81.4) | | Chloramphenicol | 44 | 18 (40.9) | 9 (20.5) | 17 (38.6) | | | | | | Piperacillin | | | | | 68 | 58 (85.3) | 4 (5.9) | 6 (8.8) | | Ceftazidime | | | | | 66 | 23 (31.8) | | 43 (65.2) | | Cefepime | | | | | 62 | 25 (40.3) | | 37 (59.7) | | Imipenem | | | | | 70 | 65 (92.9) | | 5 (7.1) | | Meropenem | | | | | 70 | 64 (91.4) | 1 (1.4) | 5 (7.1) |
|
|
